Measurement of quetiapine and four quetiapine metabolites in human plasma by LC-MS/MS. - Wikidata - wikimedia - TriplyDB

Measurement of quetiapine and four quetiapine metabolites in human plasma by LC-MS/MS.

Measurement of quetiapine and four quetiapine metabolites in human plasma by LC-MS/MS.

http://www.wikidata.org/entity/Q34126160

about

Active metabolites as antidepressant drugs: the role of norquetiapine in the mechanism of action of quetiapine in the treatment of mood disorders Plasma quetiapine in relation to prescribed dose and other factors: data from a therapeutic drug monitoring service, 2000-2011 Development and validation of a high-performance liquid chromatography-tandem mass spectrometric method for simultaneous determination of bupropion, quetiapine and escitalopram in human plasma.Liquid chromatography tandem mass spectrometry in the clinical laboratory.Rapid determination of quetiapine in blood by gas chromatography-mass spectrometry. Application to post-mortem cases.

P2860

Q21129108-347A01EA-C8B6-4650-AA47-A7372D587634 Q30685511-665E5354-9ED6-4798-9521-4FDAA41FE41B Q35282145-9F886DBB-86E0-4623-87AE-A87654BA89DC Q38260022-A34C4CC5-68DA-4D00-B1CC-17855EBF26D0 Q46943451-4CC8ECF2-A558-48A4-8B69-15AA10321258

P2860

Measurement of quetiapine and four quetiapine metabolites in human plasma by LC-MS/MS.

http://www.wikidata.org/entity/Q34126160

description

2012 nî lūn-bûn

@nan

2012 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Measurement of quetiapine and four quetiapine metabolites in human plasma by LC-MS/MS.

@ast

Measurement of quetiapine and four quetiapine metabolites in human plasma by LC-MS/MS.

@en

Measurement of quetiapine and four quetiapine metabolites in human plasma by LC-MS/MS.

@nl

type

label

Measurement of quetiapine and four quetiapine metabolites in human plasma by LC-MS/MS.

@ast

Measurement of quetiapine and four quetiapine metabolites in human plasma by LC-MS/MS.

@en

Measurement of quetiapine and four quetiapine metabolites in human plasma by LC-MS/MS.

@nl

prefLabel

Measurement of quetiapine and four quetiapine metabolites in human plasma by LC-MS/MS.

@ast

Measurement of quetiapine and four quetiapine metabolites in human plasma by LC-MS/MS.

@en

Measurement of quetiapine and four quetiapine metabolites in human plasma by LC-MS/MS.

@nl

P1433

Q34126160-AD48D98D-EF2C-422A-A493-E846EA91B7B0

P1476

Q34126160-379646EB-906A-47DB-AB5F-C3E4036CAA36

P2093

Q34126160-0DF84E44-207E-4A35-9F17-BD7A27A335D3

Q34126160-15749694-EC57-4A79-8E27-4D8AF2A74ABD

Q34126160-1604DA48-D8FB-4AD0-93FC-506315FBDE15

P2860

Q34126160-1CD916BE-823E-470A-8A1D-93E436F7D5D0

Q34126160-644647BC-11FA-4CFC-9A0A-BE047AF501B2

Q34126160-93EE1D35-28B9-43A3-87E1-75B4D53650B0

Q34126160-AA6CD628-3F9E-4E19-9730-BB29487C7DA0

Q34126160-B6AEAE4A-3C38-4803-83FE-ACFB486FE3C7

Q34126160-B70CFE38-DF71-4EA2-AE0D-7FE9FA14DF01

Q34126160-B89BD9B1-9128-47A0-90B9-5559B2DA2836

Q34126160-E5337A18-CE71-4C30-A631-01969B410224

Q34126160-FC40D212-C17B-4482-92B8-645073BFA9AD

P304

Q34126160-8B2E13A1-1434-495E-91E7-3733CA0F3ED6

P31

Q34126160-F94207E8-4297-4E61-9EBD-10B2DED1021B

P356

Q34126160-E733CC63-4AF7-4F03-AE42-28402A742C53

P433

Q34126160-74A5A46F-AA77-43EC-BBA8-D0C3FA96DF8C

P478

Q34126160-B246DCD6-116C-4D22-BC0E-6AFACE478CDA

P50

Q34126160-C595D8FF-E261-451F-95A1-F203348B1D49

P577

Q34126160-4CEF0B1D-CA21-4C0E-BB8B-0C07CE8ED39A

P698

Q34126160-19B9346B-722B-42EB-952C-63ECC240031A

P356

P1433

Biomedical Chromatography

P1476

Measurement of quetiapine and four quetiapine metabolites in human plasma by LC-MS/MS.

@en

P2093

Danielle S Fisher

http://www.w3.org/2001/XMLSchema#string

Robert J Flanagan

http://www.w3.org/2001/XMLSchema#string

Simon A Handley

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical pharmacokinetics of quetiapine: an atypical antipsychotic.

Metabolic drug interactions with newer antipsychotics: a comparative review.

Second-generation antipsychotics in major depressive disorder: update and clinical perspective.

N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity.

Relationship between dopamine D2 receptor occupancy, clinical response, and drug and monoamine metabolites levels in plasma and cerebrospinal fluid. A pilot study in patients suffering from first-episode schizophrenia treated with quetiapine.

Development and validation of an LC-MS/MS method for the determination of quetiapine and four related metabolites in human plasma.

Quetiapine serum concentrations in psychiatric patients: the influence of comedication.

Preliminary evaluation of monolithic column high-performance liquid chromatography with tris(2,2'-bipyridyl)ruthenium(II) chemiluminescence detection for the determination of quetiapine in human body fluids.

Steady-state pharmacokinetic, safety, and tolerability profiles of quetiapine, norquetiapine, and other quetiapine metabolites in pediatric and adult patients with psychotic disorders.

P304

1125-1132

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/BMC.2672

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P50

P577

2012-01-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22241669

http://www.w3.org/2001/XMLSchema#string